Cargando…
Response to Comment on Hempe et al. The Hemoglobin Glycation Index Identifies Subpopulations With Harms or Benefits From Intensive Treatment in the ACCORD Trial. Diabetes Care 2015;38:1067–1074
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Diabetes Association
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876735/ https://www.ncbi.nlm.nih.gov/pubmed/26404938 http://dx.doi.org/10.2337/dci15-0001 |
| _version_ | 1782433280681836544 |
|---|---|
| author | Hempe, James M. Liu, Shuqian Myers, Leann McCarter, Robert J. Buse, John B. Fonseca, Vivian |
| author_facet | Hempe, James M. Liu, Shuqian Myers, Leann McCarter, Robert J. Buse, John B. Fonseca, Vivian |
| author_sort | Hempe, James M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4876735 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | American Diabetes Association |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-48767352016-10-01 Response to Comment on Hempe et al. The Hemoglobin Glycation Index Identifies Subpopulations With Harms or Benefits From Intensive Treatment in the ACCORD Trial. Diabetes Care 2015;38:1067–1074 Hempe, James M. Liu, Shuqian Myers, Leann McCarter, Robert J. Buse, John B. Fonseca, Vivian Diabetes Care e-Letters: Comments and Responses American Diabetes Association 2015-10 2015-09-15 /pmc/articles/PMC4876735/ /pubmed/26404938 http://dx.doi.org/10.2337/dci15-0001 Text en © 2015 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. |
| spellingShingle | e-Letters: Comments and Responses Hempe, James M. Liu, Shuqian Myers, Leann McCarter, Robert J. Buse, John B. Fonseca, Vivian Response to Comment on Hempe et al. The Hemoglobin Glycation Index Identifies Subpopulations With Harms or Benefits From Intensive Treatment in the ACCORD Trial. Diabetes Care 2015;38:1067–1074 |
| title | Response to Comment on Hempe et al. The Hemoglobin Glycation Index Identifies Subpopulations With Harms or Benefits From Intensive Treatment in the ACCORD Trial. Diabetes Care 2015;38:1067–1074 |
| title_full | Response to Comment on Hempe et al. The Hemoglobin Glycation Index Identifies Subpopulations With Harms or Benefits From Intensive Treatment in the ACCORD Trial. Diabetes Care 2015;38:1067–1074 |
| title_fullStr | Response to Comment on Hempe et al. The Hemoglobin Glycation Index Identifies Subpopulations With Harms or Benefits From Intensive Treatment in the ACCORD Trial. Diabetes Care 2015;38:1067–1074 |
| title_full_unstemmed | Response to Comment on Hempe et al. The Hemoglobin Glycation Index Identifies Subpopulations With Harms or Benefits From Intensive Treatment in the ACCORD Trial. Diabetes Care 2015;38:1067–1074 |
| title_short | Response to Comment on Hempe et al. The Hemoglobin Glycation Index Identifies Subpopulations With Harms or Benefits From Intensive Treatment in the ACCORD Trial. Diabetes Care 2015;38:1067–1074 |
| title_sort | response to comment on hempe et al. the hemoglobin glycation index identifies subpopulations with harms or benefits from intensive treatment in the accord trial. diabetes care 2015;38:1067–1074 |
| topic | e-Letters: Comments and Responses |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876735/ https://www.ncbi.nlm.nih.gov/pubmed/26404938 http://dx.doi.org/10.2337/dci15-0001 |
| work_keys_str_mv | AT hempejamesm responsetocommentonhempeetalthehemoglobinglycationindexidentifiessubpopulationswithharmsorbenefitsfromintensivetreatmentintheaccordtrialdiabetescare20153810671074 AT liushuqian responsetocommentonhempeetalthehemoglobinglycationindexidentifiessubpopulationswithharmsorbenefitsfromintensivetreatmentintheaccordtrialdiabetescare20153810671074 AT myersleann responsetocommentonhempeetalthehemoglobinglycationindexidentifiessubpopulationswithharmsorbenefitsfromintensivetreatmentintheaccordtrialdiabetescare20153810671074 AT mccarterrobertj responsetocommentonhempeetalthehemoglobinglycationindexidentifiessubpopulationswithharmsorbenefitsfromintensivetreatmentintheaccordtrialdiabetescare20153810671074 AT busejohnb responsetocommentonhempeetalthehemoglobinglycationindexidentifiessubpopulationswithharmsorbenefitsfromintensivetreatmentintheaccordtrialdiabetescare20153810671074 AT fonsecavivian responsetocommentonhempeetalthehemoglobinglycationindexidentifiessubpopulationswithharmsorbenefitsfromintensivetreatmentintheaccordtrialdiabetescare20153810671074 |